Calcipotriol monotherapy versus calcipotriol plus UVA1 versus calcipotriol plus narrow-band UVB in the treatment of psoriasis

Drugs under Experimental and Clinical Research

Volumn 31, Issue 5-6, 2005, Pages 169-174

  Roussaki Schulze, A V ^a   Kouskoukis, C ^b   Klimi, E ^a   Zafiriou, E ^a   Galanos, A ^c   Rallis, E ^a,d  

^a UNIVERSITY OF THESSALY   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

^d NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; MALE; MONOTHERAPY; OUTCOMES RESEARCH; PHOTOTHERAPY; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; PSORIASIS VULGARIS; SCORING SYSTEM; ULTRAVIOLET B RADIATION;

ADULT; AGED; CALCITRIOL; COMBINED MODALITY THERAPY; DERMATOLOGIC AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PSORIASIS; ULTRAVIOLET THERAPY;

EID: 30144435331     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Ramsay B., O'Reagan M. A survey of the social and psychological effects of psoriasis. Br. J. Dermatol., 118(2), 195, 1988.
2. Bonnekoh B., Gollinick H. Psoriasis. In: Katsambas A., Lotti T. (Eds.). "European Handbook of Dermatological Treatments." Second edition. Springer-Verlag Berlin, Heidelberg, New York, 2003, pp. 433-450.
3. Han RD., Cohen R.D. Managing immunogenic responses to infliximab: Treatment implications for patients with Crohn's disease. Drugs, 64(16), 1767, 2004.
4. Mohan A.K., Cote T.R., Block J.A., Manadan A.M., Siegel J.N., Braun M.M. Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor. Clin. Infect. Dis., 39(3), 295, 2004.
5. Krutmann J. Phototherapy for atopic dermatitis. In: Hanifin J. (Ed.). "Dermatologic Therapy, Management of Atopic Dermatitis: Current Status and Future Possibilities." Munksgaard International Publishers Ltd., Copenhagen, 1996, pp. 24-31.
6. Molin L. Topical calcipotriol combined with phototherapy for psoriasis. The results of two randomized trials and review of the literature. Calcipotriol - UVB Study Group. Dermatology, 198(4), 375, 1996.
7. Zanolli M.D., Feldman S.R., Clark A.R., Fleischer A.B. Patient instructions and protocols, psoriasis. In. "Phototherapy Treatment Protocols." The Parthenon Publishing Group, New York, 1999, pp. 7-59.
8. Fogh K., Kragballe K. Vitamin D3 analogues in dermatologic therapy. In: Christophers E., Wolff K. (Eds.). "Dermatologic Therapy. Treatment of Psoriasis." Munksgaard International Publishers Ltd., Copenhagen, 1999, pp. 29-31.
9. Feldman S.R. Psoriasis treatment. In: Gallen J.R, Jorizzo J.L., (Eds.). "Current Problems in Dermatology." Mosby Inc., St. Louis, 1998, 10(1), pp. 1-40.
10. Kang S., Yi S., Griffiths C.E., Fancher L., Hamilton T.A. Choi C.H. Calcipotriene-induced improvement in psoriasis is associated with reduced interleukin-8 and increased interleukin-10 levels within lesions, Br. J. Dermatol., 138(1), 77, 1998.
11. de Rie M.A., Out T.A., Bos J.D. Low-dose narrow-band UVB phototherapy combined with topical therapy is effective in psoriasis and does not inhibit systemic T-cell activation. Dermatology, 196(4) 991, 1998.
12. Nguyen T.Q., Young M.S., Menter A. Ultraviolet B phototherapy for psoriasis. In: Bergstresser PR. (Ed.). "Dermatologic Treatment. Photoprotective Therapy." Munksgaard International Publishers Ltd., Copenhagen, 1997, p. 4
13. Longuet-Perret I., Schmitt D., Viac J. Tumor necrosis factor alpha is involved in the contrasting effects of ultraviolet B and ultraviolet A1 radiation on the release by normal human keratinocytes of vascular permeability factor. Br. J. Dermatol., 138(2), 221, 1998.
14. Jones C.D., Guokian M., el-Ghorr A.A., Gibbs N.K., Norval M. Effects of phototherapy on the production of cytokines by peripheral blood mononuclear cells and on systemic antibody responses in patients with psoriasis. Photodermatol. Photoimmunol. Photomed., 12(5), 204, 1996.
15. Moodycliffe A.M., Kimber I., Norval M. Role of tumour necrosis factor-α in ultraviolet B light-induced dendritic cell migration and suppression of contact hypersensitivity. Immunology, 81(1), 79, 1994.
16. McGarth H. Jr. Ultraviolet A1 phototherapy for lupus erythematosus. In: Bergstresser RR. (Ed.). "Dermatologic Therapy. Photoprotective Therapy." Munksgaard International Publishers Ltd., Copenhagen, 1997, p. 109.
17. Schwarz T. Effecte von ultravioletter Strahlung auf das Immunsystem. JDDG, 2(1), 142, 2003.
18. Kreuter A., Gamblicher T., Avermaete A., et al. Low-dose ultraviolet A1 phototherapy for extragenital lichen sclerosus: Results of a preliminary study. J. Am. Acad. Dermatol., 46(2), 251, 2002.
19. Krutmann J. The treatment of psoriasis: UVB In: Christophers E., Wolff K. (Eds.). "Dermatologic Therapy. Treatment of Psoriasis." Munksgaard International Publishers Ltd., Copenhagen, 1999, p. 32.